The MDA-MB-468 breast cancer cell line shows very low expression of CD31 and SIRPalpha as ascertained by Affymetrix gene profiling (Tables S1A and S1B) and immunofluorescent staining followed by FACS analysis (Figures S1 and S2). This evidence concerns the gene SIRPA and breast cancer.